Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Pamidronic acid

Drug Profile

Pamidronic acid

Alternative Names: AHPrBP; Amino hydroxypropylidene diphosphonic acid; Aminomux; APD; Aredia; CGP 23339A; CGP 23339AE; Disodium aminohydroxypropylidenediphosphonate; Disodium pamidronate; IG 7913; Pamidronate sodium; Panorin

Latest Information Update: 04 Nov 2018

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Gador; Henkel
  • Developer Andromaco; Drogueria Marco-Med; Gador Paraguay; Hanlim Pharmaceutical; Leti; MAC Laboratories; Nippon Kayaku; Novartis; Raices; Seignior Pharma; Sued Farmaceutica
  • Class Antihypercalcaemics; Bisphosphonates; Calcium regulators; Osteoporosis therapies; Small molecules
  • Mechanism of Action Bone resorption factor inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Cancer metastases; Malignant hypercalcaemia; Osteitis deformans; Osteogenesis imperfecta; Osteoporosis; Postmenopausal osteoporosis
  • No development reported Bone cancer; Cancer pain

Most Recent Events

  • 24 Jun 2018 Biomarkers information updated
  • 24 May 2005 Clinical data from a media release have been added to the adverse events section
  • 09 Mar 2005 Data from a media release have been added to the adverse events section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top